PureLife Revenue and Competitors
Estimated Revenue & Valuation
- PureLife's estimated annual revenue is currently $7.3M per year.
- PureLife's estimated revenue per employee is $216,000
Employee Data
- PureLife has 34 Employees.
- PureLife grew their employee count by 13% last year.
PureLife Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $350M | 926 | 15% | N/A | N/A |
#2 | $4.9M | 26 | -4% | N/A | N/A |
#3 | $17M | 70 | -22% | N/A | N/A |
#4 | $34.6M | 128 | 21% | N/A | N/A |
#5 | $24M | 89 | -20% | N/A | N/A |
#6 | $88.8M | 299 | 6% | N/A | N/A |
#7 | $122.9M | 364 | 14% | N/A | N/A |
#8 | $16.5M | 68 | 24% | N/A | N/A |
#9 | $663.3M | 1718 | 18% | $1.1B | N/A |
#10 | $1690M | 793 | 34% | N/A | N/A |
What Is PureLife?
Established in 2009, PureLife offers dental health professionals a unique combination of name-brand products, compelling prices and high-touch service, so “better health†can be a realistic part of every purchase decision they make. From complete waste solutions to everyday dental supplies, PureLife empowers practitioners to make a positive difference in the health of their patients and staff, and in their environmental impact.
keywords:N/AN/A
Total Funding
34
Number of Employees
$7.3M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PureLife News
Pure Life Organics Pure Neuro is a supplement that helps with nerve pain treatment. The nerves are protected, and the unique blend of strong...
Cephalon; Purelife Bioscience; Peak Nootropics; Nootrico; SupNootropic Biological Technology; AlternaScript; Accelerated Intelligence; Onnit Labs; Powder City...
Purelife bioscience Co., Ltd. Peak Nootropics AlternaScript, LLC. Liquid Health, Inc. Natural Factors Nutritional Products Ltd. Reckitt...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.6M | 34 | 21% | N/A |
#2 | $6.7M | 34 | 0% | N/A |
#3 | $3.9M | 34 | -3% | N/A |
#4 | $4.5M | 34 | 10% | N/A |
#5 | $3.9M | 34 | N/A | N/A |